Abivax S.A. (ABVX) has a market capitalization of $8.25B and trades at $125.80. The 52-week range is 4.77-148.83.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -27.1, Earnings Per Share (EPS) of $-4.65.
The stock has a beta of -0.10, operates in the Healthcare sector.